e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Safety of and interactions between current treatments for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Budesonide augments formoterol-induced bronchodilation of human small airways within minutes
Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri
Source:
International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Session:
Safety of and interactions between current treatments for asthma and COPD
Session type:
Thematic Poster Session
Number:
998
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri. Budesonide augments formoterol-induced bronchodilation of human small airways within minutes. Eur Respir J 2015; 46: Suppl. 59, 998
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Pharmacologic bronchodilation response to salbutamol in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014
More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
BioPhysical bronchodilator: A new class of respiratory drug
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma
Source: Eur Respir J 2008; 32: 1224-1230
Year: 2008
Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
Source: Eur Respir J 2007; 30: 653-661
Year: 2007
Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Ciclesonide improves measures of small airway involvement in asthma
Source: Eur Respir J 2008; 31: 1213-1220
Year: 2008
Investigating the interaction between bronchoconstriction and cough in asthma
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Source: Eur Respir J 2003 Dec 01;22(6):926-930
Year: 2003
Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Decametoxine influence on bronchial hyperreactivity in patients with bronchial asthma
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept